In rats, co-injection of AAV-GBA1 with AAV-A53T a-synuclein into the substantia nigra prevented a-synuclein-mediated degeneration of nigrostriatal dopamine neurons by 6 months. These neuroprotective effects were associated with altered protein expression of markers of autophagy.